356 related articles for article (PubMed ID: 32493025)
21. Coamplification of 12q15 and 12p13 and homozygous CDKN2A/2B deletion: synergistic role of fibrosarcomatous transformation in dermatofibrosarcoma protuberans with a cryptic COL1A1-PDGFB fusion.
Lu Y; Li T; Chen M; Peng H; Du T; Qiu Y; Zhang H
Virchows Arch; 2022 Aug; 481(2):313-319. PubMed ID: 35171326
[TBL] [Abstract][Full Text] [Related]
22. Congenital dermatofibrosarcoma protuberans with fibrosarcomatous and myxoid change.
Gu W; Ogose A; Kawashima H; Umezu H; Kudo N; Hotta T; Endo N
J Clin Pathol; 2005 Sep; 58(9):984-6. PubMed ID: 16126884
[TBL] [Abstract][Full Text] [Related]
23. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.
Thway K; Noujaim J; Jones RL; Fisher C
Ann Diagn Pathol; 2016 Dec; 25():64-71. PubMed ID: 27806849
[TBL] [Abstract][Full Text] [Related]
24. Dermatofibrosarcoma Protuberans: What Is This?
Vitiello GA; Lee AY; Berman RS
Surg Clin North Am; 2022 Aug; 102(4):657-665. PubMed ID: 35952694
[TBL] [Abstract][Full Text] [Related]
25. Remission with Imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans--a case report.
Lemm D; Muegge LO; Hoeffken K; Aklan T; Mentzel T; Thorwarth M; Schultze-Mosgau S
Oral Maxillofac Surg; 2008 Dec; 12(4):209-13. PubMed ID: 18751744
[TBL] [Abstract][Full Text] [Related]
26. Dermatofibrosarcoma protuberans, fibrosarcomatous variant: A rare tumor in children.
Chicaud M; Frassati-Biaggi A; Kaltenbach S; Karanian M; Orbach D; Fraitag S
Pediatr Dermatol; 2021 Jan; 38(1):217-222. PubMed ID: 33010051
[TBL] [Abstract][Full Text] [Related]
27. Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change.
Minter RM; Reith JD; Hochwald SN
J Surg Oncol; 2003 Mar; 82(3):201-8. PubMed ID: 12619065
[TBL] [Abstract][Full Text] [Related]
28. Dermatofibrosarcoma protuberans: Clinicopathological spectrum with emphasis on lymph node metastasis and fibrosarcomatous transformation.
Dahiya S; Tomar R; Ahuja M; Mallya V; Mandal S; Khurana N; Rathi AK
J Cancer Res Ther; 2022 Dec; 18(Supplement):S439-S443. PubMed ID: 36511000
[TBL] [Abstract][Full Text] [Related]
29. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans.
Zhang Z; Chen H; Chen M; He X; Wang Y; Zhang H
J Dermatol; 2017 Jul; 44(7):798-802. PubMed ID: 28150334
[TBL] [Abstract][Full Text] [Related]
30. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans.
Sheng WQ; Hashimoto H; Okamoto S; Ishida T; Meis-Kindblom JM; Kindblom LG; Hisaoka M
J Pathol; 2001 May; 194(1):88-94. PubMed ID: 11329146
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation.
Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Osaki J; Ono T; Adachi Y; Tsuchiya R; Toda Y; Ogura K; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2023 Nov; 36(6):2187-2194. PubMed ID: 37490236
[TBL] [Abstract][Full Text] [Related]
32. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
[TBL] [Abstract][Full Text] [Related]
33. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of the COL1A1-PDGFB fusion gene in a case of dermatofibrosarcoma protuberans with a fibrosarcoma component].
Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Calabuig S; Botella R; Nagore E; Requena C; Guillén C; Cremades A; Pellín A; Llombart-Bosch A
Actas Dermosifiliogr; 2006 Jun; 97(5):337-41. PubMed ID: 16956568
[TBL] [Abstract][Full Text] [Related]
35. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL
Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
[TBL] [Abstract][Full Text] [Related]
36. Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment.
Tazzari M; Indio V; Vergani B; De Cecco L; Rini F; Negri T; Camisaschi C; Fiore M; Stacchiotti S; Dagrada GP; Casali PG; Gronchi A; Astolfi A; Pantaleo MA; Villa A; Lombardo C; Arienti F; Pilotti S; Rivoltini L; Castelli C
J Invest Dermatol; 2017 Feb; 137(2):484-493. PubMed ID: 27608549
[TBL] [Abstract][Full Text] [Related]
37. Dermatofibrosarcoma protuberans with platelet-derived growth factor-D rearrangement; two cases with morphologically distinct presentations.
Campbell K; Bridge JA; DiMaio D; Wilson J; Shalin SC; Gardner JM
J Cutan Pathol; 2022 Mar; 49(3):274-277. PubMed ID: 34628665
[TBL] [Abstract][Full Text] [Related]
38. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
[TBL] [Abstract][Full Text] [Related]
39. Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review.
Navarrete-Dechent C; Mori S; Barker CA; Dickson MA; Nehal KS
JAMA Dermatol; 2019 Mar; 155(3):361-369. PubMed ID: 30601909
[TBL] [Abstract][Full Text] [Related]
40. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.
Maki RG; Awan RA; Dixon RH; Jhanwar S; Antonescu CR
Int J Cancer; 2002 Aug; 100(6):623-6. PubMed ID: 12209598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]